MIRA Pharmaceuticals, Inc. Common Stock
MIRAMIRA Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for neurological and psychiatric disorders. The company aims to address unmet medical needs through its research-driven pipeline, utilizing novel drug delivery systems and targeted treatments.
Company News
Mira Pharmaceuticals saw significant after-hours stock price increase following preclinical data announcement for Mira-55, a non-psychotropic marijuana compound that demonstrated superior pain reduction compared to morphine in animal studies.
Over 50 companies are advancing cannabinoid drug research, exploring potential treatments for mental health disorders, neurodegenerative diseases, and chronic inflammation, with promising clinical trials targeting conditions like Alzheimer's, pain management, and epilepsy.
Mira Pharmaceuticals has approved the acquisition of SKNY Pharmaceuticals, creating a combined enterprise value of over $60 million. The deal is expected to bring together the companies' pipelines and market opportunities.
KernelDAO, a top restaking protocol, has partnered with Mira, a pioneer in trustless verified AI technology, to launch a first-of-its-kind API that enhances AI reliability through trustless verification. The partnership aims to address key challenges in the AI industry, including reducing system downtime and errors through trustless verification.
Shares of MariaDB plc (NYSE: MRDB) rose sharply in today’s pre-market trading after Progress Software (NASDAQ: PRGS) announced that it is possibly considering an offer for the company. MariaDB shares jumped 100.4% to $0.4530 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Destiny Tech100 Inc (NASDAQ: DX...
